VRANKEN-POMMERY MONOPOLE - Revenue for the first half of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
33
VRANKEN-POMMERY MONOPOLE - Revenue for the first half of 2018 €94.8m - Recurring business up 6.3% - Priority to margins

Financial press release

Revenue for the first half of 2018: €94.8m Recurring business up 6.3% Priority to margins

Reims, 16 July 2018

Strong growth in brands +6.3%

Total revenue in €m 30/06/2018 30/06/2017 Change %
Champagnes 76.4  73.3  +3.1 +4.2%
Provence and Camargue wines 6.0  5.0  +1.0 +20.8%
Other (Portos, sparkling wines, other) 10.0  8.7  +1.3 +14.9%
Group brand sales 92.5 87.0 +5.5 +6.3%
Listel (*) 0.9  5.3  -4.4 NS
Inter-industry (semi-finished products) and generic sales (**) 1.4  9.1  -7.7 NS
Revenue 94.8  101.4 -6.6  -6,5% (***)
(*) Listel left the scope of consolidation in July 2017 - residual sales in H1 2018    
(**) Inter-industry sales are carried forward to the second half (***) Non significant evolution due to the sale of 50% participation in Listel SAS      

Vranken-Pommery Monopole is continuing to strengthen its export positions in order to continue growing its international business. For the first time, the weight of the subsidiaries, established in capitals strategic for sales of champagne and wine, made it possible to reverse the trend in group sales, with the international segment now in the lead. In the first half of 2018, export sales of champagne exceeded domestic sales to reach 51.2%. International growth buttressed the leading position of Vranken-Pommery Monopole, which was acquired in France by its leading champagne brands. For the nine subsidiaries, this redistribution of sales paves the way for strong growth both for champagne and for the Provence and Camargue Domaines and Châteaux.

1 - Brand sales In the first half of 2018, the group's recurring business was very robust, generating an increase in revenue of more than 6.3%. All of the group's activities recorded growth. In the Champagne segment, the development of the Vranken and Pommery & Greno premium brands is continuing both in France and abroad. The group's innovation policy contributes to value creation by marketing attractive new vintages. This momentum is driven widely by creations such as Vranken's "Brut Nature" and Pommery's "Royal Blue Sky - on ice" and Blanc de Blancs. The American "Louis Pommery" sparkling wine, launched in the second half of 2017, is continuing to expand successfully in all the US States. From September, the wines developed in Camargue (Brut and Rosé) under the label "Brut de France" will be rolled out in all European countries. In Provence and Camargue, the commercial referencing by leading European and American clients, which was obtained in 2018 for the Provence Château La Gordonne and the Camargue "Pink Flamingo", helped to increase sales volumes at end-June 2018, firmly establishing the positioning of the Domaines and Châteaux in these key markets. In the Douro Valley, the repositioning on the premium qualities of Porto Rozes was successfully completed and Douro Wines are continuing to establish themselves in all sales channels.  2 - Listel  The Listel brand left the group's scope of consolidation in July 2017. Vranken-Pommery Monopole recorded the last, modest sales of Listel in the first half of 2018. 3. Inter-industry sales In the Champagne segment, low-margin inter-industry sales were carried forward to the second half. This non-recurring business is set to decrease in the coming years. It is only intended to secure stocks at a level ensuring the smooth development of the brands over the long term. This development started during the first half of 2018 for Champagne Pommery & Greno in major export markets, as well as for the Camargue Pink Flamingo and the Provence Château La Gordonne. The group, which owns and manages more than 2,500 ha of vineyards, has all the supplies necessary to steer the sales of its Maisons, Domaines and Châteaux towards significant business development. While caution is always in order, the group is pleased to note, so far, signs of a good harvest in all the vineyards, including in Camargue where significant volume losses had been recorded in the last two years.

Next release

Publication of the 2018 interim financial report: 10 September 2018

About Vranken-Pommery Monopole :

Vranken-Pommery Monopole is the second largest Champagne group.

With sites in Champagne, Provence, Camargue and Douro, it is Europe's leading wine grower.

Its brand portfolio includes:

  • the Champagne brands Vranken, Pommery & Greno, Heidsieck & Co Monopole, Charles Lafitte, et Bissinger & Co
  • the Rozes et Sao Pedro ports, and Terras do Grifo Douro wines ;
  • the Camargue Domaine Royal de Jarras, and Provence Chateau La Gordonne ;
  • the Sparkling Wines : Louis Pommery California, Louis Pommery England, and Brut de France. 

Vranken-Pommery Monopole is listed on NYSE Euronext (Paris and Brussels). (Codes "VRAP" (Paris), and "VRAB" (Brussels); ISIN: FR0000062796).

Contacts

Vranken-Pommery Monopole: Franck Delval, Head of Financial Controls +33 3 26 61 62 34, comfi@vrankenpommery.fr Press Claire Doligez, +33 1 53 70 74 25, cdoligez@image7.fr Caroline Simon, +33 1 53 70 74 65, caroline.simon@image7.fr

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 114

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 99

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Veterans United Foundation Marks 15 Years of Giving

Updated Category News Views 0

A Milestone Measured in More Than Checks Fifteen years can turn a workplace charity into background noise, but this one plainly has not drifted into autopilot. Veterans United Foundation closed its 2026 anniversary campaign, called The Good Goes On, with $1.5 million directed to charitable organizations, 1,145 employee volunteers, and 2,680 hours of hands-on work. That is...

Continue Reading
Polsen Flex Deal Puts Pre-Tax Funds Behind Wearables

Updated Category News Views 52

A pile of soon-to-expire FSA cash is a peculiar sales catalyst, but Polsen Health has found one. The Amsterdam-based preventative-health wearable company is partnering with Flex to let customers pay for every Polsen watch and strap using eligible HSA or FSA funds at checkout. No reimbursement chase, no claim forms, and buyers can split the cost with another card. For a...

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 305

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 319

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
Kawneer’s OptiQ Window Wins a Useful Design Signal

Updated Category News Views 24

Three Nods, One Very Practical Product Claim Windows rarely stir much excitement outside an architect’s specification binder, but Kawneer has put together a respectable run with its OptiQ Offset Fixed/Projected Series Window. On November 18, 2026, the architectural aluminum-systems maker said the product had won in the Windows and Doors category at both the 2026...

Continue Reading
Racura's AML Trial Clears Its First Crucial Hurdle

Updated Category News Views 13

One signature from Sheba does not cure leukemia, but it does move Racura Oncology from talking about EMILI to doing the hard, expensive work of enrolling patients. For a company at this stage, that distinction matters. Ethics approval for the seamless Phase 2b/3 RC220 study in relapsed or refractory acute myeloid leukemia is a real operational milestone, not the sort of...

Continue Reading
SteriLance Aims for Smoother Pricks with NanoSense Move

Updated Category News Views 92

Revamping the Lancing Game Out there in Suzhou, SteriLance Medical is steering clear of just chasing meter accuracy—do enough folks even care about glorified electronics?—they're zeroing in on the needle part of the blood glucose test, the part that pricks your finger every damn day. Yep, this new initiative is inviting blood glucose monitoring (BGM) brands to embrace...

Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 225

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading

Top 5 Most Recently Viewed Articles

UP Oncolytics Boosts Funding to Propel Brain Cancer Research

Updated Category News Views 171

UP Oncolytics Secures Significant Grant for Research Advancement UP Oncolytics, a pioneering biotechnology company specializing in neuro-oncology, is making headlines with its latest achievement in funding. This innovative company, a spin-out from a prominent research institution, has secured a matching grant to further its mission in developing oncolytic virus therapy...

Continue Reading
US Dollar Weakness Fuels Gold's Safe Haven Appeal Amid Trade Tensions

Updated Category News Views 269

US Dollar Weakness Benefits Gold Amid Trade Concerns The US dollar has been retreating against several major currencies, largely influenced by recent dovish comments from Fed Governor Waller. The anticipation of further developments in trade negotiations is another factor keeping investors on edge as they navigate these financial currents. Fed’s Influence on the Dollar...

Continue Reading
Tesla's Strategic Partnerships with Local Suppliers in China

Updated Category News Views 468

Tesla's Strategic Partnerships with Local Suppliers in China Tesla, Inc. (NASDAQ: TSLA) is taking significant steps to enhance its operational efficiency and local presence in the world's largest automotive market, China. Recently reported developments indicate that the iconic electric vehicle manufacturer has successfully established partnerships with over 400 local...

Continue Reading
Collect a Unique Piece of History: Trump Bobblehead Release

Updated Category News Views 324

Royal Bobbles Launches Limited Edition Bobblehead of President-Elect Trump Add an Iconic Piece of Presidential Inauguration History with a One-of-a-Kind President-Elect Donald J. Trump Bobblehead A Historic Collectible Honoring Strength and Patriotism Royal Bobbles, recognized as the original bobblehead maker, has made an exciting announcement. They are launching the 2025...

Continue Reading
Extant Capital's New $200 Million Investment Marks Growth Path

Updated Category News Views 219

Extant Capital Receives Significant Investment Boost Extant Capital, an alternative asset management firm, has made an exciting announcement regarding a substantial new investment. The firm has successfully secured a $200 million cornerstone investment from New Holland Capital, marking a pivotal moment in its growth journey. This strategic partnership is set to enhance...

Continue Reading